Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine
复制标题

血清素转运蛋白 (5-HTT) 启动子基因型可能影响催乳素对氯米帕明的反应

DOI:
--
复制
发表时间:
2000
期刊:
影响因子:
3.4
通讯作者:
P. Cowen
P. Cowen
中科院分区:
医学3区
文献类型:
--
作者:
R. Whale;D. Quested;D. Laver;Paul J. Harrison;P. Cowen

文献摘要

被引文献

相似文献

Abstract.Rationale:人5-羟色胺(5-HT)转运蛋白(5-HTT)基因启动子区的44个碱基对插入/缺失多态性产生被称为长(1)和短(s)的双等位基因多态性。s变体与5-HTT位点的较低表达和5-HT再摄取效率降低相关。目的:本研究的目的是确定急性5-HT再摄取阻断所产生的脑5-HT功能的增加是否受到5-HTT启动子l/s多态性的影响。研究方法:我们采用安慰剂对照的交叉设计,在14名健康女性受试者(7名ss基因型和7名ll基因型)中测量了急性给予三环类抗抑郁药氯丙咪嗪后血浆催乳素的增加,作为5-HT神经传递的指标。结果:氯丙咪嗪诱导催乳素释放与ll基因型的受试者显着更大。结论:我们的研究结果表明,急性5-羟色胺再摄取阻滞产生更大的增加5-羟色胺神经传递的受试者与ll基因型比那些与ss基因型。这些结果与临床数据一致,表明ss基因型受试者对选择性5-羟色胺再摄取抑制剂(SSRI)单药治疗的疗效较差。
Abstract.Rationale: A 44-base-pair insertion/deletion polymorphism in the promoter region of the human serotonin (5-HT) transporter (5-HTT) gene gives rise to a biallelic polymorphism designated long (l) and short (s). The s variant is associated with a lower expression of 5-HTT sites and a reduced efficiency of 5-HT reuptake. Objective: The aim of the present study was to determine whether the increase in brain 5-HT function produced by acute 5-HT reuptake blockade is influenced by the 5-HTT promoter l/s polymorphism. Methods: We measured the increase in plasma prolactin that follows acute administration of the tricyclic antidepressant clomipramine as an index of 5-HT neurotransmission in 14 healthy female subjects (7 with ss genotype and 7 with ll genotype) using a placebo-controlled crossover design. Results: Clomipramine-induced prolactin release was significantly greater in subjects with the ll genotype. Conclusion: Our findings suggest that acute 5-HT reuptake blockade produces a greater increase in 5-HT neurotransmission in subjects with the ll genotype than in those with an ss genotype. These results are consistent with clinical data indicating that subjects with an ss genotype may have a poorer therapeutic response to selective serotonin reuptake inhibitor (SSRI) monotherapy.